Tg(hs1336-cre/ERT2,-GFP)1651Jlr
Transgene Detail
|
Symbol: |
Tg(hs1336-cre/ERT2,-GFP)1651Jlr |
Name: |
transgene insertion 1651, John Rubenstein |
MGI ID: |
MGI:5705384 |
Synonyms: |
1336-CreER-IRES-GFP |
Transgene: |
Tg(hs1336-cre/ERT2,-GFP)1651Jlr Location: unknown
|
Alliance: |
Tg(hs1336-cre/ERT2,-GFP)1651Jlr page
|
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase, Reporter) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(hs1336-cre/ERT2,-GFP)1651Jlr expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
human |
hs1336 |
|
|
|
|
Mutation details: This transgene contains the human enhancer element hs1336, which is within the BMP binding endothelial regulator (BMPER) gene on human Chr 7, followed by a minimal Hsp68 promoter, the cre/ERT2 fusion gene, an internal ribosomal entry site (IRES), and a green fluorescent protein reporter gene. The fusion gene encodes Cre recombinase joined to a modified ligand-binding domain of the human estrogen receptor that preferentially binds tamoxifen or 4-hydroxytamoxifen, but not endogenous 17beta-estradiol; upon binding to tamoxifen, the cre/ERT2 protein is translocated to the nucleus.
(J:94077)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
hs1336
(human)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:94077 Mutant Mouse Regional Resource Centers, Information obtained from the Mutant Mouse Regional Resource Centers (MMRRC). Unpublished. 2004-2015; |
All: |
1 reference(s) |
|